Navigation Links
Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
Date:2/6/2008

WEIFANG, China, Feb. 6 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI.OB) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China and glucose and starch products that serve as raw materials for food, beverage and industrial production, today announced that it will conduct a conference call at 9:00 a.m. Eastern Time on Friday, February 15, 2008 to discuss the second quarter results of fiscal year 2008.

Shengtai Pharmaceutical's Chief Financial Officer, Mr. Yizhao Zhang will be participating in the conference call. The Company plans to make an earnings announcement prior to the call.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 866-800-8648. International callers should dial 617-614-2702. When prompted by the operator, mention Conference Passcode 835 628 35.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Friday, February 15 at 11:00 a.m. Eastern Time. To access the replay, dial 888-286-8010, international callers should dial 617-801-6888, and enter the passcode 497 603 34.

About Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly-owned subsidiary Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier of glucose products, which include pharmaceutical grade glucose used for medical purposes, and glucose and cornstarch products for the food and beverage industry and for industrial production in China. For more information about Shengtai Pharmaceutical, Inc. please visit http://www.shengtaipharmaceutical.com.

Safe Harbor Stat
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
4. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
5. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
6. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
7. A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.
8. Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation
9. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. Angiotech to participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...YWARD, Calif., Nov. 6 Intarcia The...on its ITCA 650 (DUROS® continuous delivery o...iabetes at the Ninth Annual Diabetes Technology Me...ww.newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO )...tide Via ITCA 650 Lowers Plasma Glucose, HbA1c and...
(Date:11/5/2009)...LLINGTON, Colo., Nov. 5 The endang...s in the western U.S. This rare carnivore feeds o...tible to plague and often entire population die-of...ervice (FWS) has implemented a ferret breeding pro...ts into their formerly native habitat. Unfortunat...
(Date:11/5/2009)...nference Call on Thursday, November 5, 2009 at 4:3...ER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharm...ASDAQ: OGXI ) today reported unaudited financial ...d September 30, 2009 and reviewed the Company,s hi...following consolidated results reflect the operati...
(Date:11/5/2009)...RT WORTH, Texas, Nov. 5 ...nced today that it has entered into a Letter of In...Virtual Health Technologies, Inc. (OTC Bulletin Bo...$1,000,000 in cash and debt, 4,000,000 shares of W... by WNDM on the Veriscrip technology being acquire...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...g, Va. -- Fullerenes, also fondly known as buckyba...red in 1985, the hollow carbon atoms have been ada...s ranging from electronics to carriers of imaging ... water hating, carbon molecules clump together in ...s. And there are reports that these aggregates can...
...INGS, Colo., April 8, 2008 HemoGenix(R),Inc., a p...ent company,reported that the USPTO has issued the...company,s HALO(R) technology. HALO(R) is the 21st,...placement for, the,traditional colony-forming cell...as developed and validated by HemoGenix(R) with th...
...ass., April 8, 2008 Caliper Life,Sciences, Inc. (...al Meeting,of Stockholders will be held on June 3,...ated at 68 Elm Street, Hopkinton, Massachusetts. T...o vote at this meeting is April 16,2008., About C...premier provider of cutting-edge,technologies enab...
Other Biology Technology:Citrate appears to control buckyball clumping but environmental concerns remain 2Citrate appears to control buckyball clumping but environmental concerns remain 3HemoGenix(R), Inc. Receives Issued Patent for its HALO(R) Technology Platform From the United States Patent and Trademark Office (USPTO). 2HemoGenix(R), Inc. Receives Issued Patent for its HALO(R) Technology Platform From the United States Patent and Trademark Office (USPTO). 3
(Date:11/4/2009)...n has received more than $10 million in research g...deral stimulus program, bringing thetotal amount o...23 million. Thirty-three projects achieved stimul... weather. , "The university has thoughtfully und...scholarly excellence to federal agency priorities....
(Date:11/4/2009)...wire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE ), a...etrics software, today reported financial results ... ,, Michael Tzannes, Aware,s Chairman and Chief...nced an agreement to sell our DSL and home network...ductor company being spun out of Infineon. This t...
(Date:11/4/2009)...-- Global Rainmakers, Inc., an intellectual proper..., today announced that the company has exited its ...ialize its suite of technologies designed to lever..., During the past four years, the company has spe...oy a series of core--but expandable--technologies ...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 1Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 2Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 3Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 4Peregrine Pharmaceuticals Licenses Anti VEGF Antibodies to Affitech 13142 5GSK Improving Performance to Continue in Second Half 52381 1Red Mango Introduces the First Probiotic Iced Tea July 27 52379 1Red Mango Introduces the First Probiotic Iced Tea July 27 52379 2Red Mango Introduces the First Probiotic Iced Tea July 27 52379 3Red Mango Introduces the First Probiotic Iced Tea July 27 52379 4
...the results may not rival the artistry of glassblo...he National Institute of Standards and Technology ... a new fabrication technique called "nanoglassblow... fluidic devices used to isolate and study single ...nds. The novel method is described in a paper post...
...teins upon which life depends share an attribute w...just won,t fly. , But researchers have been puzzl... the ribosome factories in a cell are folded into ...ion. They only have known that for many of the mos...s place out of sight, hidden in the inner cavity o...
...RGHUniversity of Pittsburgh-led researchers discov... can grow on surfaces and that drug-tolerant strai...search team recently reported in Molecular Microb...y human tuberculosis (TB) requires months of inten... cause of the relapses that can nonetheless occur....
Other Biology News:'Nanoglassblowing' seen as boon to study of individual molecules 2Researchers reveal insights into hidden world of protein folding 2Researchers reveal insights into hidden world of protein folding 3Researchers reveal insights into hidden world of protein folding 4Source of drug-tolerant tuberculosis possibly behind TB relapses, intensity of treatment 2
...he family of calcium binding proteins such as calm...pha and beta chain whereas S100B is composed of tw...the antigen presenting cells such as the Langerhan...s in the paracortex of lymph nodes. Epitope: Not...
Cytosol / Particulate Rapid Separation Kit from MBL International
EIA Well-Cover Sheets from Cayman Chemical
Rabbit Anti-Human CLAN Polyclonal Antibody, Unconjugated from IMGENEX
Biology Products: